Antigen
  • CXCL16
  • CXCLG16
  • SR-PSOX
  • SRPSOX
  • 0910001K24Rik
  • AV290116
  • BB024863
  • CXCL16v1
  • CXCL16v2
  • Zmynd15
  • b2b498Clo
  • chemokine (C-X-C motif) ligand 16
  • chemokine (C-X-C motif) ligand 14
  • scavenger receptor for phosphatidylserine and oxidized low density lipoprotein
  • CXCL16
  • CXCL14
  • Cxcl16
  • SR-PSOX
Reactivity
Human Alternatives
Method Type
Sandwich ELISA
Detection Range
46.875-3000 pg/mL
Minimum Detection Limit
46.875 pg/mL
Application
ELISA
Options
Supplier
Supplier Product No.
\"Independent
  • Successfully validated (ELISA)
  • by CGIBD Advanced Analytics Core
  • No. #029789
  • Date 08/12/2014
  • Read full report (PDF)
  • Click to verify
\"Chemokine \"Chemokine \"Chemokine
Lot Number Q03184077
Method validated ELISA
Positive Control Human serum - expression is 1.3 ng/mL
Negative Control Goat serum (non-reactive species)
Notes Target protein was detected in the positive control sample and not in the negative control sample as expected.

Full Methods

Images back to top

Full Methods

Controls
  • Positive control: Human serum (Sigma Aldrich, Cat# H6914-20ML, Lot# SLBK2170V)
  • Negative control: Goat serum (Sigma Aldrich, Cat# G9023-10ML, Lot# SLBH2670V)
Protocol
  • 1. All reagents were brought up to room temperature for 30 minutes prior to use. The 1x Wash Buffer was prepared by adding 20 mL of 25x Wash Buffer Concentrate to 480 mL of distilled/deionized water and mixing thoroughly.
  • 2. The vial of Standard was reconstituted with 1 mL of Sample Diluent, mixed, and allowed to sit for 15 minutes with gentle agitation.
  • 3. The standard curve was prepared by creating a 2-fold dilution series of seven standards (including the original undiluted vial) using Sample Diluent. Sample Diluent alone served as the 0 pg/mL standard.
  • 4. The assay plate was removed from the foil pouch and 100 μL of each standard and sample were added to the appropriate wells, in triplicate. The plate was covered with the adhesive strip provided and incubated for 2 hours at 37 °C.
  • 5. Approximately 10 minutes before the incubation ended, a 1x Biotin-antibody solution was prepared by diluting 60 μL of 100x Biotin-antibody into 5940 μL of Biotin-antibody Diluent.
  • 6. The liquid from each well was removed.
  • 7. 100 μL of 1x Biotin-antibody solution was added to each well, and the plate was covered with a new adhesive strip, and incubated for 1 hour at 37 °C.
  • 8. Approximately 10 minutes before the incubation ended, a 1x HRP-avidin solution was prepared by diluting 60 μL of 100x HRP-avidin into 5940 μL of HRP-avidin Diluent.
  • 9. Each well was aspirated and washed, repeating the process two times for a total of three washes. Each well was washed by filling each well with 1x Wash Buffer and letting it stand for 2 minutes. After the last wash, remaining Wash Buffer was removed and the plate was inverted and blotted against clean, absorbent paper towels.
  • 10. 100 μL of 1x HRP-avidin solution was added to each well, the plate was covered with a new adhesive strip, and incubated for 1 hour at 37 °C.
  • 11. The aspiration/wash procedure from Step 9 was repeated for an additional 5 washes.
  • 12. 90 μL of TMB Substrate was added to each well. The plate was protected from light and incubated for 15-30 minutes at 37 °C, with periodic checking to prevent overdevelopment.
  • 13. 50 μL of Stop Solution was added to each well and mixed thoroughly. The optical density (OD) of each well was measured within 5 minutes using a microplate reader set to 450 nm.
  • 14. A standard curve was generated by plotting the OD value for each standard on the y-axis against the concentration on the x-axis. A line of best fit through the points on the graph was used to generate an equation to calculate CXCL16 concentrations of the samples based on their average OD values.
Experimental Notes The TMB substrate (Lot 03190614) used for this assay was light blue prior to addition. The 1:100 dilution of the positive control (human serum) reported much higher values than its less dilute counterparts and should be treated as outliers.